MRI Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

MRI Systems Pipeline Market Report Overview

Magnetic Resonance Imaging (MRI) generates clear and detailed images of internal organs and tissues using radiofrequency and a strong magnetic field. MRI is generally preferred for the diagnosis of brain and other neurological disorders. The 3T, 1.5T and 0.2-1.2T MRI systems have been tracked under this category.

The MRI Systems pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·        1.5T MRI Systems

·        3T MRI Systems

·        0.2T-1.2T MRI Systems

Key Territories ·        The US

·        Europe

·        Canada

·        China

·        Taiwan

Key Regulatory Paths ·        510(k)

·        CE

·        UKCA

·        MDL

·        NMPA

Leading Companies ·        Advanced Biomedical Informatics Group LLC

·        Advanced Imaging Research Inc

·        Advanced MRI Technologies

·        AHS Cancer Control Alberta

·        Anatomyworks LLC

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

MRI Systems Pipeline Market by Segments

The key segments in the MRI Systems pipeline market are 1.5T MRI Systems, 3T MRI Systems, and 0.2T-1.2T MRI Systems. As of December 2023, 1.5T MRI Systems accounted for the highest number of pipeline products. The 1.5T MRI Systems includes MRI Systems with 1.5 Tesla in field strength.

MRI Systems Pipeline Market Analysis by Segments, 2023 (%)

MRI Systems Pipeline Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segment Insights into the MRI Systems Pipeline Market

Download a Free Report Sample

MRI Systems Pipeline Market Segmentation by Territories

A few of the key territories for MRI Systems pipeline products are the US, Europe, Canada, China, and Taiwan among others. As of December 2023, the US accounted for the highest number of pipeline products.

MRI Systems Pipeline Market Analysis by Territories, 2023 (%)

MRI Systems Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the MRI Systems Pipeline Market

Download a Free Report Sample

MRI Systems Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths followed by the MRI Systems pipeline market are 510(k), CE, UKCA, MDL, and NMPA among others. As of December 2023, 510(k) was the most followed pathway for pipeline products in the market.

MRI Systems Pipeline Market Analysis by Regulatory Paths, 2023 (%)

MRI Systems Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy the Full Report for More Regulatory Path Insights into the MRI Systems Pipeline Market

Download a Free Report Sample

MRI Systems Pipeline Market – Competitive Landscape

A few of the key companies associated with the MRI Systems pipeline market are Advanced Biomedical Informatics Group LLC, Advanced Imaging Research Inc., Advanced MRI Technologies, AHS Cancer Control Alberta, and Anatomyworks LLC, among others.

Advanced Imaging Research Inc (AIR): AIR is headquartered in Cleveland, Ohio, the US. It develops and sells medical devices and surface coils for pediatric MRI and MR spectroscopy applications. The company offers products many products such as such as MRI conditional accessories, novel surface coils, and MRI neo ventilators. In addition, it provides hoses, oxygen and air cylinders, magnetic resonance imaging system accessories, and magnetic resonance spectroscopy system accessories. AIR’s products are used for the ventilation, transportation, and monitoring of premature babies and newborns. The company offers its products through its network of clients and distributors.

MRI Systems Pipeline Market Analysis by Companies, 2023

MRI Systems Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the MRI Systems Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

MRI Systems Pipeline Market Segments Outlook

  • 5T MRI Systems
  • 3T MRI Systems
  • 2T-1.2T MRI Systems

MRI Systems Pipeline Market Territories Outlook

  • The US
  • Europe
  • Canada
  • China
  • Taiwan

MRI Systems Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • UKCA
  • MDL
  • NMPA

Scope

This report provides:

  • Extensive coverage of the MRI Systems under development.
  • An exhaustive list of major pipeline products and their details, including product descriptions, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of MRI Systems and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report will enable you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of MRI Systems under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Advanced Biomedical Informatics Group LLC
Advanced Imaging Research Inc
Advanced MRI Technologies
AHS Cancer Control Alberta
Anatomyworks LLC
ASG Superconductors SpA
Aspect Imaging Inc
Boston Children's Hospital
Brigham and Women's Hospital
C4 Imaging, LLC
Cincinnati Children's Hospital Medical Center
Clear Cut Medical Ltd.
Collagen Medical LLC
DeepSpin GmbH
Diagnosoft Inc
Duke University
Eyas Medical Imaging Inc
Focal Healthcare Inc
GE Global Research
GE HealthCare Technologies Inc
General Electric Global Research Center
Georgetown University
Harvard University
Hebrew University of Jerusalem
Hugo W. Moser Research Institute at Kennedy Krieger Inc
Hyperfine Inc
Icahn School of Medicine at Mount Sinai
Intellidesign Pty Ltd
Johns Hopkins University
Koninklijke Philips NV
Lausanne University Hospital
Leiden University
Leiden University Medical Center
Lucidity LLC
Marvel Medtech LLC
Massachusetts General Hospital
Max Delbruck Center for Molecular Medicine
Medical College of Wisconsin
MicroMRI Inc
MRI Robotics LLC
MyBrain Co Ltd
National University of Science and Technology MiSiS
Neoscan Solutions GmbH
Neuro42 Inc
Neusoft Medical Systems Co Ltd
New York University School of Medicine
Newcastle University
Ningbo Xingaoyi Medical Instruments Co. Ltd
Northwestern University
Oregon Health & Science University
Philips Healthcare
PhysioMRI Tech SL
Prism Clinical Imaging, Inc.
Promaxo Inc
Resonance Health Ltd
Robin Medical, Inc.
Shanghai United Imaging Healthcare Co Ltd
Shanghai United Imaging Intelligence Co Ltd
Siemens Healthineers AG
Singapore General Hospital
Stanford University
Superconducting Systems Inc
Synaptive Medical Inc
Tel Aviv University
The University of Manchester
The University of Nottingham
Time Medical, Inc.
Tornado Spectral Systems
University of Arizona
University of California Davis
University of California Los Angeles
University of Colorado
University of Colorado Boulder
University of Florida
University of Hong Kong
University of Illinois
University of Louisville
University of Michigan
University of Queensland
University of Saskatchewan
University of Strasbourg
University of Texas Southwestern Medical Center
University of Virginia
University of Washington
Vanderbilt University
Varian Medical Systems Inc
VisionQuest Biomedical LLC
Weinberg Medical Physics LLC
Weizmann Institute of Science
Wipro GE Healthcare Pvt Ltd
Wright State University

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 11

|1.2 List of Figures 19

2 Introduction 20

2.1 MRI Systems Overview 20

3 Products under Development 21

3.1 MRI Systems – Pipeline Products by Stage of Development 21

3.2 MRI Systems – Pipeline Products by Segment 22

3.3 MRI Systems – Pipeline Products by Territory 23

3.4 MRI Systems – Pipeline Products by Regulatory Path 24

3.5 MRI Systems – Pipeline Products by Estimated Approval Date 25

3.6 MRI Systems – Ongoing Clinical Trials 26

4 MRI Systems – Pipeline Products under Development by Companies 27

4.1 MRI Systems Companies – Pipeline Products by Stage of Development 27

4.2 MRI Systems – Pipeline Products by Stage of Development 31

5 MRI Systems Companies and Product Overview 35

5.1 Advanced Biomedical Informatics Group LLC Company Overview 35

5.1.1 Advanced Biomedical Informatics Group LLC Pipeline Products & Ongoing Clinical Trials Overview 35

5.2 Advanced Imaging Research Inc Company Overview 36

5.2.1 Advanced Imaging Research Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.3 Advanced MRI Technologies Company Overview 37

5.3.1 Advanced MRI Technologies Pipeline Products & Ongoing Clinical Trials Overview 37

5.4 AHS Cancer Control Alberta Company Overview 39

5.4.1 AHS Cancer Control Alberta Pipeline Products & Ongoing Clinical Trials Overview 39

5.5 Anatomyworks LLC Company Overview 40

5.5.1 Anatomyworks LLC Pipeline Products & Ongoing Clinical Trials Overview 40

5.6 ASG Superconductors SpA Company Overview 41

5.6.1 ASG Superconductors SpA Pipeline Products & Ongoing Clinical Trials Overview 41

5.7 Aspect Imaging Inc Company Overview 43

5.7.1 Aspect Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.8 Boston Children’s Hospital Company Overview 44

5.8.1 Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 44

5.9 Brigham and Women’s Hospital Company Overview 45

5.9.1 Brigham and Women’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 45

5.10 C4 Imaging, LLC Company Overview 48

5.10.1 C4 Imaging, LLC Pipeline Products & Ongoing Clinical Trials Overview 48

5.11 Cincinnati Children’s Hospital Medical Center Company Overview 49

5.11.1 Cincinnati Children’s Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 49

5.12 Clear Cut Medical Ltd. Company Overview 50

5.12.1 Clear Cut Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 50

5.13 Collagen Medical LLC Company Overview 65

5.13.1 Collagen Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 65

5.14 DeepSpin GmbH Company Overview 66

5.14.1 DeepSpin GmbH Pipeline Products & Ongoing Clinical Trials Overview 66

5.15 Diagnosoft Inc Company Overview 67

5.15.1 Diagnosoft Inc Pipeline Products & Ongoing Clinical Trials Overview 67

5.16 Duke University Company Overview 68

5.16.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 68

5.17 Eyas Medical Imaging Inc Company Overview 70

5.17.1 Eyas Medical Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview 70

5.18 Focal Healthcare Inc Company Overview 71

5.18.1 Focal Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 71

5.19 GE Global Research Company Overview 72

5.19.1 GE Global Research Pipeline Products & Ongoing Clinical Trials Overview 72

5.20 GE HealthCare Technologies Inc Company Overview 74

5.20.1 GE HealthCare Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 74

5.21 General Electric Global Research Center Company Overview 76

5.21.1 General Electric Global Research Center Pipeline Products & Ongoing Clinical Trials Overview 76

5.22 Georgetown University Company Overview 77

5.22.1 Georgetown University Pipeline Products & Ongoing Clinical Trials Overview 77

5.23 Harvard University Company Overview 78

5.23.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 78

5.24 Hebrew University of Jerusalem Company Overview 79

5.24.1 Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 79

5.25 Hugo W. Moser Research Institute at Kennedy Krieger Inc Company Overview 80

5.25.1 Hugo W. Moser Research Institute at Kennedy Krieger Inc Pipeline Products & Ongoing Clinical Trials Overview 80

5.26 Hyperfine Inc Company Overview 82

5.26.1 Hyperfine Inc Pipeline Products & Ongoing Clinical Trials Overview 82

5.27 Icahn School of Medicine at Mount Sinai Company Overview 88

5.27.1 Icahn School of Medicine at Mount Sinai Pipeline Products & Ongoing Clinical Trials Overview 88

5.28 Intellidesign Pty Ltd Company Overview 89

5.28.1 Intellidesign Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 89

5.29 Johns Hopkins University Company Overview 90

5.29.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 90

5.30 Koninklijke Philips NV Company Overview 92

5.30.1 Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview 92

5.31 Lausanne University Hospital Company Overview 95

5.31.1 Lausanne University Hospital Pipeline Products & Ongoing Clinical Trials Overview 95

5.32 Leiden University Company Overview 96

5.32.1 Leiden University Pipeline Products & Ongoing Clinical Trials Overview 96

5.33 Leiden University Medical Center Company Overview 97

5.33.1 Leiden University Medical Center Pipeline Products & Ongoing Clinical Trials Overview 97

5.34 Lucidity LLC Company Overview 98

5.34.1 Lucidity LLC Pipeline Products & Ongoing Clinical Trials Overview 98

5.35 Marvel Medtech LLC Company Overview 99

5.35.1 Marvel Medtech LLC Pipeline Products & Ongoing Clinical Trials Overview 99

5.36 Massachusetts General Hospital Company Overview 102

5.36.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 102

5.37 Max Delbruck Center for Molecular Medicine Company Overview 105

5.37.1 Max Delbruck Center for Molecular Medicine Pipeline Products & Ongoing Clinical Trials Overview 105

5.38 Medical College of Wisconsin Company Overview 106

5.38.1 Medical College of Wisconsin Pipeline Products & Ongoing Clinical Trials Overview 106

5.39 MicroMRI Inc Company Overview 108

5.39.1 MicroMRI Inc Pipeline Products & Ongoing Clinical Trials Overview 108

5.40 MRI Robotics LLC Company Overview 109

5.40.1 MRI Robotics LLC Pipeline Products & Ongoing Clinical Trials Overview 109

5.41 MyBrain Co Ltd Company Overview 110

5.41.1 MyBrain Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 110

5.42 National University of Science and Technology MiSiS Company Overview 111

5.42.1 National University of Science and Technology MiSiS Pipeline Products & Ongoing Clinical Trials Overview 111

5.43 Neoscan Solutions GmbH Company Overview 112

5.43.1 Neoscan Solutions GmbH Pipeline Products & Ongoing Clinical Trials Overview 112

5.44 Neuro42 Inc Company Overview 113

5.44.1 Neuro42 Inc Pipeline Products & Ongoing Clinical Trials Overview 113

5.45 Neusoft Medical Systems Co Ltd Company Overview 114

5.45.1 Neusoft Medical Systems Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 114

5.46 New York University School of Medicine Company Overview 115

5.46.1 New York University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 115

5.47 Newcastle University Company Overview 118

5.47.1 Newcastle University Pipeline Products & Ongoing Clinical Trials Overview 118

5.48 Ningbo Xingaoyi Medical Instruments Co. Ltd Company Overview 119

5.48.1 Ningbo Xingaoyi Medical Instruments Co. Ltd Pipeline Products & Ongoing Clinical Trials Overview 119

5.49 Northwestern University Company Overview 120

5.49.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 120

5.50 Oregon Health & Science University Company Overview 122

5.50.1 Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview 122

5.51 Philips Healthcare Company Overview 123

5.51.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 123

5.52 PhysioMRI Tech SL Company Overview 124

5.52.1 PhysioMRI Tech SL Pipeline Products & Ongoing Clinical Trials Overview 124

5.53 Prism Clinical Imaging, Inc. Company Overview 125

5.53.1 Prism Clinical Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview 125

5.54 Promaxo Inc Company Overview 126

5.54.1 Promaxo Inc Pipeline Products & Ongoing Clinical Trials Overview 126

5.55 Resonance Health Ltd Company Overview 127

5.55.1 Resonance Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 127

5.56 Robin Medical, Inc. Company Overview 130

5.56.1 Robin Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 130

5.57 Shanghai United Imaging Healthcare Co Ltd Company Overview 132

5.57.1 Shanghai United Imaging Healthcare Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 132

5.58 Shanghai United Imaging Intelligence Co Ltd Company Overview 136

5.58.1 Shanghai United Imaging Intelligence Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 136

5.59 Siemens Healthineers AG Company Overview 137

5.59.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 137

5.60 Singapore General Hospital Company Overview 145

5.60.1 Singapore General Hospital Pipeline Products & Ongoing Clinical Trials Overview 145

5.61 Stanford University Company Overview 146

5.61.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 146

5.62 Superconducting Systems Inc Company Overview 149

5.62.1 Superconducting Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 149

5.63 Synaptive Medical Inc Company Overview 150

5.63.1 Synaptive Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 150

5.64 Tel Aviv University Company Overview 151

5.64.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 151

5.65 The University of Manchester Company Overview 152

5.65.1 The University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 152

5.66 The University of Nottingham Company Overview 153

5.66.1 The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 153

5.67 Time Medical, Inc. Company Overview 154

5.67.1 Time Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 154

5.68 Tornado Spectral Systems Company Overview 155

5.68.1 Tornado Spectral Systems Pipeline Products & Ongoing Clinical Trials Overview 155

5.69 University of Arizona Company Overview 156

5.69.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 156

5.70 University of California Davis Company Overview 157

5.70.1 University of California Davis Pipeline Products & Ongoing Clinical Trials Overview 157

5.71 University of California Los Angeles Company Overview 158

5.71.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 158

5.72 University of Colorado Company Overview 160

5.72.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 160

5.73 University of Colorado Boulder Company Overview 162

5.73.1 University of Colorado Boulder Pipeline Products & Ongoing Clinical Trials Overview 162

5.74 University of Florida Company Overview 163

5.74.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 163

5.75 University of Hong Kong Company Overview 164

5.75.1 University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 164

5.76 University of Illinois Company Overview 165

5.76.1 University of Illinois Pipeline Products & Ongoing Clinical Trials Overview 165

5.77 University of Louisville Company Overview 166

5.77.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 166

5.78 University of Michigan Company Overview 167

5.78.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 167

5.79 University of Queensland Company Overview 168

5.79.1 University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 168

5.80 University of Saskatchewan Company Overview 169

5.80.1 University of Saskatchewan Pipeline Products & Ongoing Clinical Trials Overview 169

5.81 University of Strasbourg Company Overview 170

5.81.1 University of Strasbourg Pipeline Products & Ongoing Clinical Trials Overview 170

5.82 University of Texas Southwestern Medical Center Company Overview 171

5.82.1 University of Texas Southwestern Medical Center Pipeline Products & Ongoing Clinical Trials Overview 171

5.83 University of Virginia Company Overview 172

5.83.1 University of Virginia Pipeline Products & Ongoing Clinical Trials Overview 172

5.84 University of Washington Company Overview 173

5.84.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 173

5.85 Vanderbilt University Company Overview 175

5.85.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 175

5.86 Varian Medical Systems Inc Company Overview 178

5.86.1 Varian Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 178

5.87 VisionQuest Biomedical LLC Company Overview 179

5.87.1 VisionQuest Biomedical LLC Pipeline Products & Ongoing Clinical Trials Overview 179

5.88 Weinberg Medical Physics LLC Company Overview 180

5.88.1 Weinberg Medical Physics LLC Pipeline Products & Ongoing Clinical Trials Overview 180

5.89 Weizmann Institute of Science Company Overview 181

5.89.1 Weizmann Institute of Science Pipeline Products & Ongoing Clinical Trials Overview 181

5.90 Wipro GE Healthcare Pvt Ltd Company Overview 182

5.90.1 Wipro GE Healthcare Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 182

5.91 Wright State University Company Overview 184

5.91.1 Wright State University Pipeline Products & Ongoing Clinical Trials Overview 184

6 MRI Systems- Recent Developments 185

6.1 Nov 27, 2023: Siemens Appoints Hakan Ozdemir as CEO of Smart Infrastructure in the Middle East 185

6.2 Nov 26, 2023: Philips Showcases World’s First Mobile MRI System With Helium-Free Operations at RSNA23 185

6.3 Nov 23, 2023: Siemens Healthineers Receives Additional 510(K) Clearance For MAGNETOM Avanto Fit 185

6.4 Nov 23, 2023: Siemens Healthineers Receives Additional 510(K) Clearance For MAGNETOM Skyra Fit 186

6.5 Nov 22, 2023: Oxford Instruments Brings Hill & Smith CFO Hannah Nichols to Board 186

6.6 Nov 22, 2023: Oxford Instruments Names Hill & Smith CFO to Its Board 186

6.7 Nov 22, 2023: Oxford Instruments Announces Appointment of Independent Non-Executive Director 186

6.8 Nov 20, 2023: Hyperfine Announces Presentations on Clinical Advancements at RSNA 2023 186

6.9 Nov 20, 2023: Concord Medical Schedules 2023 Annual Meeting of Shareholders 187

6.10 Nov 17, 2023: SyntheticMR: Nomination Committee Appointed for the 2024 Annual General Meeting 187

6.11 Nov 14, 2023: Fonar Announces Financial Results for the First Quarter of Fiscal 2024 188

6.12 Nov 14, 2023: Oxford Instruments Reports Interim Results for the Six Months to 30 September 2023 190

6.13 Nov 10, 2023: SyntheticMR Announces Interim Report July – September 2023 191

6.14 Nov 08, 2023: Siemens Healthineers Receives Additional 510(K) Clearance For Magnetom Lumina System 192

6.15 Nov 08, 2023: Siemens Healthineers Receives Additional 510(K) Clearance For MAGNETOM Aera 192

6.16 Nov 08, 2023: Siemens Healthineers Receives Additional 510(K) Clearance For MAGNETOM Skyra 192

6.17 Nov 08, 2023: Siemens Healthineers Receives Additional 510(K) Clearance For Magnetom Prisma MRI Scanner 193

6.18 Nov 08, 2023: Siemens Healthineers Receives Additional 510(K) Clearance For MAGNETOM Prisma-Fit 193

6.19 Nov 06, 2023: Siemens Healthineers Receives Additional 510(K) Clearance for MAGNETOM Vida 193

6.20 Nov 06, 2023: Butterfly Network to Present at the Jefferies London Healthcare Conference 194

6.21 Nov 02, 2023: Butterfly Network Reports Third Quarter 2023 Financial Results 194

6.22 Oct 31, 2023: GE HealthCare Reports Third Quarter 2023 Financial Results 195

6.23 Oct 26, 2023: Hyperfine Receives Additional 510(K) Clearance For Swoop Portable MR Imaging System 197

6.24 Oct 26, 2023: ContextVision Reports Q3 Results 197

6.25 Oct 25, 2023: Esaote’s New S-Scan Open Redefines Excellence in Magnetic Resonance Imaging 198

6.26 Oct 19, 2023: Ascelia Pharma Notice of Extraordinary General Meeting 198

6.27 Oct 18, 2023: Butterfly Network to Report Third Quarter 2023 Financial Results on November 2, 2023 204

6.28 Oct 13, 2023: Smil Southwest Medical Imaging Announces the First GE Healthcare Signa Hero MRI Scanner in Arizona 204

6.29 Oct 09, 2023: Hyperfine Receives FDA Clearance for Updated AI-powered Software with Improved Image Quality for All Swoop System Sequences 205

6.30 Oct 09, 2023: Thinksono Joins Butterfly Network’s AI Marketplace 206

6.31 Oct 03, 2023: One Call Names Howard Cutler Chief Strategy & Network Officer 206

6.32 Oct 02, 2023: Promaxo Announces Sale of 20 Systems in the Third Quarter 2023 207

6.33 Oct 02, 2023: Oxford Instruments Welcomes New Chief Executive, Richard Tyson 207

6.34 Sep 28, 2023: FONAR Announces Financial Results for Fiscal 2023 208

6.35 Sep 26, 2023: Promaxo Receives 510(k) Clearance for Promaxo MRI System II 211

6.36 Sep 22, 2023: Concord Medical Reports Financial Results for the First Half of 2023 211

6.37 Sep 21, 2023: Siemens Healthineers Receives 510(k) Clearance for Magnetom Viato.Mobile 213

6.38 Sep 20, 2023: Aspect Imaging Receives Innovative Technology Contract from Vizient for Embrace Point of Care Neonatal MRI System 213

6.39 Sep 18, 2023: Hitachi Vantara Appoints New GM for Sub-Saharan Africa 214

6.40 Sep 14, 2023: Vista.ai Names Steve Cashman to Board of Directors 214

6.41 Sep 12, 2023: Hitachi Makes Executive Responsibility Change 214

6.42 Sep 08, 2023: Polarean Imaging : Partnership with VIDA To Streamline Adoption of Advanced MRI of the Lungs 214

6.43 Sep 07, 2023: Philips Reaches Resolution of US Economic Loss Litigation 215

6.44 Sep 06, 2023: Elucid Appoints Windi Hary to Lead Regulatory Affairs and Quality Management 216

6.45 Aug 29, 2023: CMS grants reimbursement code for the Polarean XENOVIEW™ MRI Technology 216

6.46 Aug 28, 2023: ContextVision Appoints Richard Hallstrom as Chief Financial Officer 217

6.47 Aug 25, 2023: Asiamedic Sets New Standard in Healthcare With Installation of First Signa Hero

3.0T MRI Scanner in Asia-Pacific 217

6.48 Aug 24, 2023: ContextVision Announces Strong Second Quarter With Solid Margin Growth 218

6.49 Aug 22, 2023: SyntheticMR Announces Interim Report April – June 2023 219

6.50 Aug 16, 2023: Philips Medical Systems Receives an Additional 510(k) Clearance for Ingenia Elition 219

6.51 Aug 10, 2023: Prenuvo AI-Assisted Study Uncovers Novel Correlation Between Lifestyle and Brain Volume Changes 220

6.52 Aug 10, 2023: Promaxo Appoints Chad Zaring, Chief Commercial Officer, and Matt Collins, Vice President of Marketing 221

6.53 Aug 09, 2023: Enrollment Completed for HOPE PMR Pediatric Hydrocephalus Study Using Hyperfine, Portable MR Imaging System 221

6.54 Aug 07, 2023: Sarvodaya Hospital in India deploys Fujifilm’s smart MRI machine 222

6.55 Aug 07, 2023: Game-changing Indian MRI Scanner Launched: Targets 6 billion People without Access to Cutting-edge Imaging Technologies 222

6.56 Jul 28, 2023: CoxHealth and Philips partner on virtual care solution 223

6.57 Jul 24, 2023: Fujifilm Healthcare Receives FDA 510(K) Clearance for ECHELON Synergy MRI System 224

6.58 Jul 17, 2023: ViewRay Files Voluntary Chapter 11 Petitions 224

6.59 Jul 15, 2023: Butterfly Network Announces Lay Off 225

6.60 Jul 13, 2023: Eyas installs neonatal MRI system at Cincinnati Children’s NICU 225

6.61 Jul 12, 2023: Hyperfine begins Swoop system’s multi-site observational trial 226

6.62 Jul 10, 2023: Springbok Analytics Announces Advanced Mobile MRI Capabilities for Elite Sports Organizations 226

6.63 Jul 01, 2023: Siemens Healthcare names Hariharan Subramanian as the Managing Director 227

6.64 Jun 23, 2023: GE HealthCare Advances PET/MR Capabilities with AIR Technologies 227

6.65 Jun 23, 2023: GE HealthCare Advances PET/MR Capabilities with the AIR Technologies 228

6.66 Jun 13, 2023: Shanghai United Imaging Healthcare Receives Additional 510(k) Clearance for uMR Omega 229

6.67 Jun 13, 2023: Oxford Instruments Announcement of unaudited full-year results for the 12 months to 31 March 2023 229

6.68 Jun 13, 2023: Oxford Instruments Announces Preliminary Results for the 12 Months to 31 March 2023 231

6.69 Jun 06, 2023: icometrix awarded a grant by The Michael J. Fox Foundation to research brain MRI biomarkers for Parkinson’s disease 231

6.70 Jun 04, 2023: Shanghai United Imaging Healthcare receives additional 510(k) clearance for uMR 570 232

6.71 Jun 02, 2023: Philips breakthrough MR 7700 system adds Xenon capabilities to enhance ventilation imaging at ISMRM 2023 232

6.72 Jun 02, 2023: United Imaging to Unveil Ultra-Modern MRI Technology Platform at ISMRM in Toronto 234

6.73 Jun 01, 2023: Hitachi Announces Executive Responsibility Change 234

6.74 May 24, 2023: SyntheticMR Report from Annual General Meeting 234

6.75 May 24, 2023: Siemens Healthineers invests 80 million euros in new semiconductor factory in Forchheim 235

6.76 May 23, 2023: SyntheticMR announces interim report January – March 2023 236

6.77 May 22, 2023: New Imaging Platform for MS Preclinical Trials 237

6.78 May 18, 2023: Hyperfine, receives Grant for an additional three years to utilize innovative Swoop Portable MR Imaging System in low and middle-income countries 238

6.79 May 17, 2023: United Imaging unveils a full portfolio of products at CMEF 2023, Highlighting Its AI Capabilities across Modalities 239

6.80 May 16, 2023: Jefferson Radiology implements groundbreaking MRI technology to reduce exam time by up to half 240

6.81 May 15, 2023: GE HealthCare launches new solutions for radiation therapy 240

6.82 May 15, 2023: iCAD reports financial results for first quarter ended March 31, 2023 241

6.83 May 15, 2023: Fonar announces financial results for fiscal 2023 3rd quarter and nine-month period 243

6.84 May 10, 2023: ViewRay announces first quarter 2023 results 244

6.85 May 09, 2023: ViewRay Announces announces conference call for first quarter 2023 financial results to be held after market on may 10, 2023 246

6.86 May 09, 2023: GE HealthCare Names James Saccaro Vice President and Chief Financial Officer 246

6.87 May 04, 2023: Philips Medical Systems obtains an additional 510(k) clearance the Ingenia Elition 246

6.88 May 04, 2023: Koninklijke Philips obtains an additional 510(k) clearance the MR 7700 System 247

6.89 May 04, 2023: Philips’ BlueSeal helium-free MR operations magnet wins Best New Technology Solution for Radiology award 247

6.90 May 04, 2023: Ascelia Pharma Announces Bulletin from the Annual General Meeting 248

6.91 Apr 28, 2023: Siemens to announce second quarter results FY 2023 250

6.92 Apr 27, 2023: GE HealthCare expands contrast media portfolio with launch of MRI agent Pixxoscan (gadobutrol) 250

6.93 Apr 27, 2023: Hitachi reports financial results for year ended March 31, 2023 251

6.94 Apr 25, 2023: Mediso launches next generation MRI spectrometer spinScan 252

6.95 Apr 25, 2023: Siemens, Siemens Healthineers and UCSF research partnership proves significant energy, cost and emission reduction in MRI machine operation 252

6.96 Apr 22, 2023: Philips Medical Systems obtains additional 510(k) clearance the MR 5300 System 253

6.97 Apr 22, 2023: Philips Medical Systems obtains additional 510(k) clearance the MR 7700 System 253

6.98 Apr 22, 2023: Philips Medical Systems obtains additional 510(k) clearance the Ingenia Elition 254

6.99 Apr 22, 2023: Philips Healthcare obtains additional 510(k) clearance the Ingenia

1.5T CX 254

6.100 Apr 22, 2023: Philips Healthcare obtains additional 510(k) clearance the Ingenia

1.5T 254

6.101 Apr 21, 2023: Philips Medical Systems obtains additional 510(k) clearance for Ingenia Ambition MR System 255

6.102 Apr 20, 2023: Prism Clinical Imaging and Imaging Biometrics announce relationship 255

6.103 Apr 19, 2023: Concord Medical Files 2022 Annual Report on Form 20-F 255

6.104 Apr 17, 2023: iCAD Strengthens Leadership Team with Appointment of Chief Financial Officer and New Senior Executives 256

6.105 Apr 14, 2023: Siemens Healthineers receives additional 510(k) clearance for MAGNETOM Sempra 257

6.106 Apr 14, 2023: Notice to attend the annual general meeting of SyntheticMR AB 257

6.107 Apr 13, 2023: ViewRay Announces Preliminary First Quarter 2023 Results and Updated Fiscal Year 2023 Financial Guidance; Company to Explore Strategic Alternatives to Maximize Shareholder Value 262

6.108 Apr 13, 2023: Ascelia Pharma Publishes Annual Report for 2022 263

6.109 Apr 13, 2023: Ian Barkshire to retire and Richard Tyson to be appointed as Chief Executive Officer of Oxford Instruments 264

6.110 Apr 12, 2023: ViewRay Announces Conference Call for Preliminary First Quarter 2023 Financial Results to be held Pre-Market opening on April 13, 2023 265

6.111 Apr 11, 2023: SyntheticMR publishes annual report for 2022 265

6.112 Apr 06, 2023: One Call Adds Two Veteran Executives to Board of Directors 266

6.113 Apr 04, 2023: Calyx delivers imaging biomarkers to advance neuropsychiatric treatment development 266

6.114 Apr 03, 2023: Notice of the annual general meeting in Ascelia Pharma AB 266

6.115 Mar 31, 2023: RAYUS Radiology adds new wide-Bore 3T MRI Scanner to Its fleet of industry-leading imaging solutions 270

6.116 Mar 28, 2023: Siemens Healthineers receives additional 510(k) clearance for MAGNETOM Amira 270

6.117 Mar 27, 2023: iCad lays off 28% of its workforce in restructuring plan 271

6.118 Mar 17, 2023: Bruker announces two

1.2 GHz NMR Systems orders from the UK 271

6.119 Mar 13, 2023: Hitachi Announces Executive Responsibility Changes 271

6.120 Mar 13, 2023: iCAD Announces Leadership Transition 272

6.121 Mar 13, 2023: Ascelia Pharma Mourns the Passing of Board Member Rene Spogard 272

6.122 Mar 13, 2023: iCAD Previews Fourth Quarter Financial Results, Full Report on March 28, 2023 272

6.123 Mar 10, 2023: Time Medical receives 510(k) clearance for NEONA

1.5T MRI System 273

6.124 Mar 10, 2023: Contract win for a Phase 1/2 rare neurodegenerative disease gene therapy study; value c.£0.7m. 273

6.125 Mar 09, 2023: Siemens Healthineers receives an additional 510(k) clearance for MAGNETOM Vida 273

6.126 Mar 06, 2023: Synaptive Medical awarded inaugural INOVAIT Focus Fund investments to fund MRI Project 274

6.127 Mar 06, 2023: Medic Vision’s AI-assisted technology improves efficiency at North Texas Imaging center 274

6.128 Mar 06, 2023: IMEXHS wins new radiology services contract 275

6.129 Mar 03, 2023: Nation’s first pediatric hybrid intraoperative MRI neurosurgery suite opens at Children’s Minnesota 276

6.130 Mar 02, 2023: United Imaging Healthcare unveils the world’s first whole-body ultra-high field

5.0T MRI, uMR Jupiter

5.0T, at ECR 276

6.131 Mar 02, 2023: Siteman Cancer Center at Washington University Treats 2,000th Patient with MRIdian MRI-Guided Radiation Therapy 277

6.132 Mar 01, 2023: Philips highlights AI-powered integrated diagnostic approach at ECR 2023 278

6.133 Feb 28, 2023: GE Healthcare receives 510(k) clearance for SIGNA Victor MRI Scanner 279

6.134 Feb 28, 2023: Hyperfine receives FDA clearance for Updated Software to further improve Diffusion-Weighted Imaging 279

6.135 Feb 27, 2023: ViewRay Announces Fourth Quarter and Full Year 2022 Results 280

6.136 Feb 21, 2023: Shanghai United Imaging Healthcare receives 510(k) clearance for uMR 680 281

6.137 Feb 21, 2023: Hyperfine, Swoop Portable MR Imaging System receives CE Marking after meeting comprehensive new EU MDR regulations 282

6.138 Feb 16, 2023: Promaxo announces clinical collaboration with Mount Sinai Health System and UTHealth Houston 282

6.139 Feb 14, 2023: Siemens Limited announces Q1 FY 2023 results; 80% increase in PAT from continuing operations 283

6.140 Feb 13, 2023: Hyperfine, announces FDA clearance for improved AI-powered software and expanded field of view for the Swoop Portable MR Imaging System 283

6.141 Feb 09, 2023: Latest data demonstrate potential of the Swoop Portable MR Imaging System in the follow-up of stroke patients who have received a thrombectomy 284

6.142 Feb 08, 2023: Siemens Announces Earnings Release and Financial Results for the First Quarter of Fiscal Year 2023 285

6.143 Feb 08, 2023: Siemens Announces Earnings Release Q1 FY 2023 285

6.144 Feb 06, 2023: Hyperfine Swoop Point-of-Care MRI System takes the stage at ISMRM with twelve abstract inclusions 288

6.145 Feb 03, 2023: AI-Automated MRI planning solution launched to beat waiting-list backlogs & support efficient UK community diagnostic strategies 288

6.146 Feb 02, 2023: NIH-funded researchers develop new MRI technique for pregnant patients 289

6.147 Feb 01, 2023: Hitachi Announces Executive Changes 289

6.148 Feb 01, 2023: Hitachi Annnounces Consolidated Financial Results for the Third Quarter Ended December 31, 2022 290

6.149 Feb 01, 2023: Canon posts record revenues in medical business unit 290

6.150 Jan 30, 2023: Philips to lay off 6,000 employees in drive to improve profitability 290

6.151 Jan 30, 2023: GE HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results 290

6.152 Jan 26, 2023: Elucid Appoints Scott Burger as Chief Commercial Officer 293

6.153 Jan 26, 2023: CU research team moves one step closer to printing models of life-like 3D organs 293

6.154 Jan 24, 2023: Portable cap can measure cognition with pulsed laser light 294

6.155 Jan 17, 2023: GE HealthCare to Announce Fourth Quarter and Full Year 2022 Results on January 30, 2023 296

6.156 Jan 10, 2023: GE HealthCare Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Results; Introduces 2023 Outlook 296

6.157 Jan 09, 2023: ViewRay Announces Preliminary Fourth Quarter and Full Year 2022 Results; appoints William P. “Bill” Burke as Chief Financial Officer 297

6.158 Jan 08, 2023: Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2023 298

6.159 Jan 02, 2023: Koninklijke Philips receives additional 510(k) clearance for MR 7700 300

6.160 Jan 02, 2023: Philips Medical Systems obtains additional 510(k) clearance for MR 5300 System 300

6.161 Dec 21, 2022: Resonance Health lodges MRI fibrosis provisional patent application 300

6.162 Dec 20, 2022: Hyperfine Research receives an additional 510(k) clearance for the Hyperfine Swoop Portable MRI System 302

6.163 Dec 20, 2022: Promaxo Announces Appointment of Dr. Prithipal S. Sethi as Chief Medical Officer of Urology 302

6.164 Dec 09, 2022: IXICO : Contract win for an early phase Multiple System Atrophy disease trial 302

6.165 Dec 07, 2022: New MRI scanner aims to deliver workflow and productivity fortitude to UK healthcare 303

6.166 Dec 07, 2022: Hitachi to hire 30,000 tech workers, defying global wave of layoffs 303

6.167 Dec 06, 2022: US Radiology Specialists enhances imaging capabilities at its American Health Imaging Centers in Alabama & Georgia with the addition of new MROpen EVO MRI systems from ASG Superconductors 303

6.168 Dec 06, 2022: Butterfly Announces CEO Transition 304

7 Appendix 305

7.1 Methodology 305

7.2 About GlobalData 308

7.3 Contact Us 308

7.4 Disclaimer 308

Table

MRI Systems – Pipeline Products by Stage of Development 21

MRI Systems – Pipeline Products by Segment 22

MRI Systems – Pipeline Products by Territory 23

MRI Systems – Pipeline Products by Regulatory Path 24

MRI Systems – Pipeline Products by Estimated Approval Date 25

MRI Systems – Ongoing Clinical Trials 26

MRI Systems Companies – Pipeline Products by Stage of Development 27

MRI Systems – Pipeline Products by Stage of Development 31

Advanced Biomedical Informatics Group LLC Pipeline Products & Ongoing Clinical Trials Overview 35

MRI Scanner – Product Status 35

MRI Scanner – Product Description 35

Advanced Imaging Research Inc Pipeline Products & Ongoing Clinical Trials Overview 36

Neuroimaging MRI System – Product Status 36

Neuroimaging MRI System – Product Description 36

Advanced MRI Technologies Pipeline Products & Ongoing Clinical Trials Overview 37

MRI Cerebral Perfusion Imaging Tool – Product Status 37

MRI Cerebral Perfusion Imaging Tool – Product Description 37

Multiplexed EPI Imaging Sequence – Product Status 38

Multiplexed EPI Imaging Sequence – Product Description 38

AHS Cancer Control Alberta Pipeline Products & Ongoing Clinical Trials Overview 39

Alberta Linac-MR P3 System – Product Status 39

Alberta Linac-MR P3 System – Product Description 39

Anatomyworks LLC Pipeline Products & Ongoing Clinical Trials Overview 40

Brain MR Images – Product Status 40

Brain MR Images – Product Description 40

ASG Superconductors SpA Pipeline Products & Ongoing Clinical Trials Overview 41

Multi-Channel/Multi-Nuclear 11.74T MRI System – Product Status 41

Multi-Channel/Multi-Nuclear 11.74T MRI System – Product Description 41

Rotating Open MRI Device – Product Status 42

Rotating Open MRI Device – Product Description 42

Aspect Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview 43

Stroke-dedicated MRI System – Product Status 43

Stroke-dedicated MRI System – Product Description 43

Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 44

Fetal Neuroimaging – Product Status 44

Fetal Neuroimaging – Product Description 44

Brigham and Women’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 45

Diffusion Magnetic Resonance Imaging Tool – Chronic Traumatic Encephalopathy – Product Status 45

Diffusion Magnetic Resonance Imaging Tool – Chronic Traumatic Encephalopathy – Product Description 45

Magnetic Resonance Elastography – Product Status 46

Magnetic Resonance Elastography – Product Description 46

MRI – Head And Knee Imaging – Product Status 46

MRI – Head And Knee Imaging – Product Description 47

C4 Imaging, LLC Pipeline Products & Ongoing Clinical Trials Overview 48

Sirius MRI Marker – Multi-Modality Imaging – Product Status 48

Sirius MRI Marker – Multi-Modality Imaging – Product Description 48

Cincinnati Children’s Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 49

Pediatric Cardiovascular MRI – Product Status 49

Pediatric Cardiovascular MRI – Product Description 49

Clear Cut Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 50

ClearCoast MRI System – Breast Biopsy – Product Status 50

ClearCoast MRI System – Breast Biopsy – Product Description 50

ClearCoast System – Colorectal Cancer – Product Status 51

ClearCoast System – Colorectal Cancer – Product Description 51

ClearCoast System – Head and Neck Cancer – Product Status 51

ClearCoast System – Head and Neck Cancer – Product Description 52

ClearCoast System – Lung Cancer – Product Status 52

ClearCoast System – Lung Cancer – Product Description 52

ClearCoast System – Pancreatic Cancer – Product Status 53

ClearCoast System – Pancreatic Cancer – Product Description 53

ClearCoast System – Prostate Cancer – Product Status 53

ClearCoast System – Prostate Cancer – Product Description 54

ClearCoast System – Skin Cancer – Product Status 54

ClearCoast System – Skin Cancer – Product Description 54

ClearCoast System – Thyroid Cancer – Product Status 55

ClearCoast System – Thyroid Cancer – Product Description 55

Clear Cut Medical Ltd. – Ongoing Clinical Trials Overview 56

ClearCoast System – Prostate Cancer – The ClearCoast Magnetic Resonance Outcome Post Marketing Surveillance Study 57

ClearCoast MRI System – Breast Biopsy – The ClearCoast Magnetic Resonance Outcome Post Marketing Surveillance Study 58

ClearCoast System – Skin Cancer – The ClearCoast Magnetic Resonance Outcome Post Marketing Surveillance Study 59

ClearCoast System – Colorectal Cancer – The ClearCoast Magnetic Resonance Outcome Post Marketing Surveillance Study 60

ClearCoast System – Lung Cancer – The ClearCoast Magnetic Resonance Outcome Post Marketing Surveillance Study 61

ClearCoast System – Thyroid Cancer – The ClearCoast Magnetic Resonance Outcome Post Marketing Surveillance Study 62

ClearCoast System – Pancreatic Cancer – The ClearCoast Magnetic Resonance Outcome Post Marketing Surveillance Study 63

ClearCoast System – Head and Neck Cancer – The ClearCoast Magnetic Resonance Outcome Post Marketing Surveillance Study 64

Collagen Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 65

CM-101 – Product Status 65

CM-101 – Product Description 65

DeepSpin GmbH Pipeline Products & Ongoing Clinical Trials Overview 66

Next-Gen AI-Powered MRI Machine – Product Status 66

Next-Gen AI-Powered MRI Machine – Product Description 66

Diagnosoft Inc Pipeline Products & Ongoing Clinical Trials Overview 67

Strain Encoding (SENC) Magnetic Resonance Imaging System – Product Status 67

Strain Encoding (SENC) Magnetic Resonance Imaging System – Product Description 67

Duke University Pipeline Products & Ongoing Clinical Trials Overview 68

Neuro And Body MRI – Product Status 68

Neuro And Body MRI – Product Description 68

Next-Generation MRI scanner – Product Status 69

Next-Generation MRI scanner – Product Description 69

Eyas Medical Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview 70

Ascent 3T Neonatal MRI System – Product Status 70

Ascent 3T Neonatal MRI System – Product Description 70

Focal Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 71

Fusion MR – Product Status 71

Fusion MR – Product Description 71

GE Global Research Pipeline Products & Ongoing Clinical Trials Overview 72

MRI Brain Scanner – Product Status 72

MRI Brain Scanner – Product Description 72

Wearable MRI Detector Array – Product Status 73

Wearable MRI Detector Array – Product Description 73

GE HealthCare Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 74

3.0 T Neonatal MRI Scanner – Product Status 74

3.0 T Neonatal MRI Scanner – Product Description 74

SIGNA Artist Evo – Product Status 75

SIGNA Artist Evo – Product Description 75

Value MR – Product Status 75

Value MR – Product Description 75

General Electric Global Research Center Pipeline Products & Ongoing Clinical Trials Overview 76

7T MRI System – Product Status 76

7T MRI System – Product Description 76

Georgetown University Pipeline Products & Ongoing Clinical Trials Overview 77

Diagnostic Tool – Alzheimer’s Disease – Product Status 77

Diagnostic Tool – Alzheimer’s Disease – Product Description 77

Harvard University Pipeline Products & Ongoing Clinical Trials Overview 78

Delta Relaxation Enhanced Magnetic Resonance Device – Product Status 78

Delta Relaxation Enhanced Magnetic Resonance Device – Product Description 78

Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 79

Handheld MRI Device – Product Status 79

Handheld MRI Device – Product Description 79

Hugo W. Moser Research Institute at Kennedy Krieger Inc Pipeline Products & Ongoing Clinical Trials Overview 80

GlucoCEST – Product Status 80

GlucoCEST – Product Description 80

MR Imaging – Neurological Diseases – Product Status 81

MR Imaging – Neurological Diseases – Product Description 81

Hyperfine Inc Pipeline Products & Ongoing Clinical Trials Overview 82

Portable MRI Device – Advanced Version – Product Status 82

Portable MRI Device – Advanced Version – Product Description 82

Swoop Portable MR Imaging System – Product Status 83

Swoop Portable MR Imaging System – Product Description 83

Hyperfine Inc – Ongoing Clinical Trials Overview 84

Swoop Portable MR Imaging System – A Pilot Study of Gadopiclenol for Imaging Central Nervous System (CNS) Tumors at Point of Care Magnetic Resonance Imaging (MRI) 85

Swoop Portable MR Imaging System – Acute Ischemic Stroke Detection with Portable MR 85

Swoop Portable MR Imaging System – Evaluation of Hyperfine Low Field Strength Portable Point-of-care Magnetic Resonance Imaging System in Hydrocephalus and Other Conditions Prompting Outpatient Brain Imaging 85

Swoop Portable MR Imaging System – Low Field Magnetic Resonance Imaging Assessment with Outpatients 86

Swoop Portable MR Imaging System – Point-of-care Low-field Magnetic Resonance Imaging in Acute Stroke (POCS) Study 86

Swoop Portable MR Imaging System – Portable MRI for Children with Neurological Injury-A Pilot Study using Hydrocephalus as an Index Condition 86

Portable MRI Device – Advanced Version – Assessing Brain Injury Using Portable Magnetic Resonance Imaging in Patients With Extracorporeal Membrane Oxygenation 87

Icahn School of Medicine at Mount Sinai Pipeline Products & Ongoing Clinical Trials Overview 88

7T MRI – MDD – Product Status 88

7T MRI – MDD – Product Description 88

Intellidesign Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 89

Low Field MRI Portable System – Product Status 89

Low Field MRI Portable System – Product Description 89

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 90

Intravascular Magnetic Resonance Imaging – Product Status 90

Intravascular Magnetic Resonance Imaging – Product Description 90

MRI-Based Cancer Detection Device – Product Status 91

MRI-Based Cancer Detection Device – Product Description 91

Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview 92

MR Ingenia 1.5T System With InSightec Exablate Neuro Platform – Product Status 92

MR Ingenia 1.5T System With InSightec Exablate Neuro Platform – Product Description 92

MR Ingenia 3.0T With InSightec Exablate Neuro Platform – Product Status 93

MR Ingenia 3.0T With InSightec Exablate Neuro Platform – Product Description 93

MR Ingenia Elition 3.0T With InSightec Exablate Neuro Platform – Product Status 93

MR Ingenia Elition 3.0T With InSightec Exablate Neuro Platform – Product Description 94

Lausanne University Hospital Pipeline Products & Ongoing Clinical Trials Overview 95

3D Motion-Resolved Free-Running MRI Tool – Product Status 95

3D Motion-Resolved Free-Running MRI Tool – Product Description 95

Leiden University Pipeline Products & Ongoing Clinical Trials Overview 96

Plasma Antenna – Product Status 96

Plasma Antenna – Product Description 96

Leiden University Medical Center Pipeline Products & Ongoing Clinical Trials Overview 97

Multi-Information MRI – Product Status 97

Multi-Information MRI – Product Description 97

Lucidity LLC Pipeline Products & Ongoing Clinical Trials Overview 98

B0 Shimming Device – Product Status 98

B0 Shimming Device – Product Description 98

Marvel Medtech LLC Pipeline Products & Ongoing Clinical Trials Overview 99

Solada – 4D – Product Status 99

Solada – 4D – Product Description 99

Solada – AT – Product Status 100

Solada – AT – Product Description 100

Solada – R – Product Status 100

Solada – R – Product Description 101

Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 102

3D Magnetic Resonance Spectroscopic Imaging Device – Product Status 102

3D Magnetic Resonance Spectroscopic Imaging Device – Product Description 102

Head Only MRI Scanner – Product Status 103

Head Only MRI Scanner – Product Description 103

Three-Bore Magnet Extremity MRI Scanner – Product Status 103

Three-Bore Magnet Extremity MRI Scanner – Product Description 104

Max Delbruck Center for Molecular Medicine Pipeline Products & Ongoing Clinical Trials Overview 105

Fast Spin Echo MRI System – Product Status 105

Fast Spin Echo MRI System – Product Description 105

Medical College of Wisconsin Pipeline Products & Ongoing Clinical Trials Overview 106

MR Based Electrical Impedance Tomography – Breast Cancer – Product Status 106

MR Based Electrical Impedance Tomography – Breast Cancer – Product Description 106

Multi-Parametric MR Imaging – Spinal Disc Degeneration – Product Status 107

Multi-Parametric MR Imaging – Spinal Disc Degeneration – Product Description 107

MicroMRI Inc Pipeline Products & Ongoing Clinical Trials Overview 108

Virtual Bone Biopsy System – Product Status 108

Virtual Bone Biopsy System – Product Description 108

MRI Robotics LLC Pipeline Products & Ongoing Clinical Trials Overview 109

MRI-Guided Breast Biopsy Device – Product Status 109

MRI-Guided Breast Biopsy Device – Product Description 109

MyBrain Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 110

Brain MRI Device – Product Status 110

Brain MRI Device – Product Description 110

National University of Science and Technology MiSiS Pipeline Products & Ongoing Clinical Trials Overview 111

Russian MRI Device – Product Status 111

Russian MRI Device – Product Description 111

Neoscan Solutions GmbH Pipeline Products & Ongoing Clinical Trials Overview 112

Neoscan MRI System – Product Status 112

Neoscan MRI System – Product Description 112

Neuro42 Inc Pipeline Products & Ongoing Clinical Trials Overview 113

Portable Head And Brain MRI Scanner – Product Status 113

Portable Head And Brain MRI Scanner – Product Description 113

Neusoft Medical Systems Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 114

High Field MRI Scanner – Product Status 114

High Field MRI Scanner – Product Description 114

New York University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 115

Magnetic Resonance Imaging Reconstruction – Product Status 115

Magnetic Resonance Imaging Reconstruction – Product Description 115

MRI Glove – Product Status 116

MRI Glove – Product Description 116

Pediatric MR Imaging – Product Status 116

Pediatric MR Imaging – Product Description 117

Newcastle University Pipeline Products & Ongoing Clinical Trials Overview 118

Motor Unit MRI – Product Status 118

Motor Unit MRI – Product Description 118

Ningbo Xingaoyi Medical Instruments Co. Ltd Pipeline Products & Ongoing Clinical Trials Overview 119

1.5T Rotatable Dual-Gesture MRI Scanner – Product Status 119

1.5T Rotatable Dual-Gesture MRI Scanner – Product Description 119

Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 120

MRI Cardiac Stress Test – Product Status 120

MRI Cardiac Stress Test – Product Description 120

MRI-Based – Cerebral Oxygen Extraction Fraction – Product Status 121

MRI-Based – Cerebral Oxygen Extraction Fraction – Product Description 121

Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview 122

Contrast-Enhanced Magnetic Resonance Imaging Apparatus – Product Status 122

Contrast-Enhanced Magnetic Resonance Imaging Apparatus – Product Description 122

Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 123

Magnetic Particle Imaging Scanner – Product Status 123

Magnetic Particle Imaging Scanner – Product Description 123

PhysioMRI Tech SL Pipeline Products & Ongoing Clinical Trials Overview 124

MRI Machine – Product Status 124

MRI Machine – Product Description 124

Prism Clinical Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview 125

Functional Connectivity MRI – Product Status 125

Functional Connectivity MRI – Product Description 125

Promaxo Inc Pipeline Products & Ongoing Clinical Trials Overview 126

Portable MR Imager – Product Status 126

Portable MR Imager – Product Description 126

Resonance Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 127

MRI Based Test – Liver Fibrosis – Product Status 127

MRI Based Test – Liver Fibrosis – Product Description 127

Resonance Health Ltd – Ongoing Clinical Trials Overview 128

MRI Based Test – Liver Fibrosis – A Study to Assess the Performance of Predictive Models and their Capacity to Distinguish Between Differing Fibrosis Grades 129

Robin Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 130

Head Mounted Augmented Reality System – Product Status 130

Head Mounted Augmented Reality System – Product Description 130

Head Mounted Display – Product Status 131

Head Mounted Display – Product Description 131

Shanghai United Imaging Healthcare Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 132

Fast MR Liver Imaging System – Product Status 132

Fast MR Liver Imaging System – Product Description 132

uAIFI EasySense – Product Status 133

uAIFI EasySense – Product Description 133

uAIFI QScan – Product Status 133

uAIFI QScan – Product Description 134

uAIFI SuperFlex Coil – Product Status 134

uAIFI SuperFlex Coil – Product Description 134

uMR Jupiter 5T – Product Status 135

uMR Jupiter 5T – Product Description 135

Shanghai United Imaging Intelligence Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 136

uMR 680 – Product Status 136

uMR 680 – Product Description 136

Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 137

DotGO – Product Status 137

DotGO – Product Description 138

Magnetic Resonance Fingerprinting – Product Status 138

Magnetic Resonance Fingerprinting – Product Description 138

Magnetom Cima.X – Product Status 139

Magnetom Cima.X – Product Description 139

Magnetom Lumina – Innovision – Product Status 139

Magnetom Lumina – Innovision – Product Description 140

MAGNETOM Sola – Cardiac Triggering – Product Status 140

MAGNETOM Sola – Cardiac Triggering – Product Description 140

Magnetom Terra.X – Product Status 141

Magnetom Terra.X – Product Description 141

MRI Tool – Multiple Sclerosis – Product Status 141

MRI Tool – Multiple Sclerosis – Product Description 142

Neonatal Lung Imaging MRI Tool – Product Status 142

Neonatal Lung Imaging MRI Tool – Product Description 142

Open Recon – Product Status 143

Open Recon – Product Description 143

QISS – Product Status 143

QISS – Product Description 144

Singapore General Hospital Pipeline Products & Ongoing Clinical Trials Overview 145

Multiparametric MRI – Product Status 145

Multiparametric MRI – Product Description 145

Stanford University Pipeline Products & Ongoing Clinical Trials Overview 146

Magnetic Resonance Imaging – Arteriovenous Lesions – Product Status 146

Magnetic Resonance Imaging – Arteriovenous Lesions – Product Description 146

Magnetic Resonance Imaging – Breast Cancer – Product Status 147

Magnetic Resonance Imaging – Breast Cancer – Product Description 147

Magnetic Resonance Imaging – Osteoarthritis – Product Status 147

Magnetic Resonance Imaging – Osteoarthritis – Product Description 148

MRI – Joint Replacements – Product Status 148

MRI – Joint Replacements – Product Description 148

Superconducting Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 149

Point-Of-Care 1.5 T MRI – Product Status 149

Point-Of-Care 1.5 T MRI – Product Description 149

Synaptive Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 150

0.5 T MRI system – Product Status 150

0.5 T MRI system – Product Description 150

Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 151

NMR (Nuclear Magnetic Resonance) Scanner – Product Status 151

NMR (Nuclear Magnetic Resonance) Scanner – Product Description 151

The University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 152

Magnetic Resonance Imaging – Dementia – Product Status 152

Magnetic Resonance Imaging – Dementia – Product Description 152

The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 153

PoleStar MRI Scanner – Product Status 153

PoleStar MRI Scanner – Product Description 153

Time Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 154

Neona – Product Status 154

Neona – Product Description 154

Tornado Spectral Systems Pipeline Products & Ongoing Clinical Trials Overview 155

Magnetic Resonance Imaging – Pelvic Cancer – Product Status 155

Magnetic Resonance Imaging – Pelvic Cancer – Product Description 155

University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 156

15-Minute MRI – Product Status 156

15-Minute MRI – Product Description 156

University of California Davis Pipeline Products & Ongoing Clinical Trials Overview 157

Diffusion MRI – Neurological Disorders – Product Status 157

Diffusion MRI – Neurological Disorders – Product Description 157

University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 158

Dynamic MR Angiography – Arteriovenous Malformation – Product Status 158

Dynamic MR Angiography – Arteriovenous Malformation – Product Description 158

Magnetic Resonance Imaging Device – Product Status 159

Magnetic Resonance Imaging Device – Product Description 159

University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 160

Myelin-Mapping MRI System – Product Status 160

Myelin-Mapping MRI System – Product Description 160

Susceptibility Weighted MR Imaging Device – Product Status 161

Susceptibility Weighted MR Imaging Device – Product Description 161

University of Colorado Boulder Pipeline Products & Ongoing Clinical Trials Overview 162

Functional MRI – Fibromyalgia – Product Status 162

Functional MRI – Fibromyalgia – Product Description 162

University of Florida Pipeline Products & Ongoing Clinical Trials Overview 163

Diagnostic Tool – Neurodegenerative Disease – Product Status 163

Diagnostic Tool – Neurodegenerative Disease – Product Description 163

University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 164

0.055 Tesla Brain MRI – Product Status 164

0.055 Tesla Brain MRI – Product Description 164

University of Illinois Pipeline Products & Ongoing Clinical Trials Overview 165

Magnetic Resonance Spectroscopic Imaging – Product Status 165

Magnetic Resonance Spectroscopic Imaging – Product Description 165

University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 166

Computer Aided Diagnostic System – Classifying Kidneys – Product Status 166

Computer Aided Diagnostic System – Classifying Kidneys – Product Description 166

University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 167

Magnetic Resonance Imaging – Radiation Therapy Planning – Product Status 167

Magnetic Resonance Imaging – Radiation Therapy Planning – Product Description 167

University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 168

LC Scan – Product Status 168

LC Scan – Product Description 168

University of Saskatchewan Pipeline Products & Ongoing Clinical Trials Overview 169

Portable MRI – Product Status 169

Portable MRI – Product Description 169

University of Strasbourg Pipeline Products & Ongoing Clinical Trials Overview 170

Real-time Wireless MRI Positioning Device – Product Status 170

Real-time Wireless MRI Positioning Device – Product Description 170

University of Texas Southwestern Medical Center Pipeline Products & Ongoing Clinical Trials Overview 171

Diagnostic Tool – Brain Tumor – Product Status 171

Diagnostic Tool – Brain Tumor – Product Description 171

University of Virginia Pipeline Products & Ongoing Clinical Trials Overview 172

MRI – Coronary Heart Disease – Product Status 172

MRI – Coronary Heart Disease – Product Description 172

University of Washington Pipeline Products & Ongoing Clinical Trials Overview 173

Diagnostic Imaging Tool – Stroke – Product Status 173

Diagnostic Imaging Tool – Stroke – Product Description 173

fMRI – Brain disorders – Product Status 174

fMRI – Brain disorders – Product Description 174

Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 175

MRI – Bone Fracture Risk Assessment – Product Status 175

MRI – Bone Fracture Risk Assessment – Product Description 175

MRI System – Product Status 176

MRI System – Product Description 176

Spin Echo Neuroimaging 7T – Product Status 176

Spin Echo Neuroimaging 7T – Product Description 177

Varian Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 178

Full-size MRI Scanner – Product Status 178

Full-size MRI Scanner – Product Description 178

VisionQuest Biomedical LLC Pipeline Products & Ongoing Clinical Trials Overview 179

Real-Time fMRI – Product Status 179

Real-Time fMRI – Product Description 179

Weinberg Medical Physics LLC Pipeline Products & Ongoing Clinical Trials Overview 180

Dental MRI Scanner – Product Status 180

Dental MRI Scanner – Product Description 180

Weizmann Institute of Science Pipeline Products & Ongoing Clinical Trials Overview 181

MRI Device – BBB Abnormalities – Product Status 181

MRI Device – BBB Abnormalities – Product Description 181

Wipro GE Healthcare Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 182

1.5T MRI System – Product Status 182

1.5T MRI System – Product Description 182

Digital MRI System – Product Status 183

Digital MRI System – Product Description 183

Portable MRI System – Product Status 183

Portable MRI System – Product Description 183

Wright State University Pipeline Products & Ongoing Clinical Trials Overview 184

3T MRI Scanner – Product Status 184

3T MRI Scanner – Product Description 184

Glossary 307

Figures

MRI Systems – Pipeline Products by Stage of Development 21

MRI Systems – Pipeline Products by Segment 22

MRI Systems – Pipeline Products by Territory 23

MRI Systems – Pipeline Products by Regulatory Path 24

MRI Systems – Pipeline Products by Estimated Approval Date 25

MRI Systems – Ongoing Clinical Trials 26

Frequently asked questions

MRI Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

MRI Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at MRI Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live MRI Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.